Can an external heart pump keep shock patients alive?

NCT ID NCT07769528

NEW Recruiting now Disease control Sponsor: China National Center for Cardiovascular Diseases Source: ClinicalTrials.gov ↗

First seen Aug 18, 2026 · Last updated Aug 18, 2026

Summary

This trial tests an external ventricular assist device that temporarily takes over the heart's pumping function in people with cardiogenic shock—a condition where the heart can't pump enough blood. The study enrolls 40 adults who have shock after heart surgery, can't come off a heart-lung machine, or have acute heart failure. The main goal is to see if the device can successfully support circulation and improve 30-day survival after it's removed, while also tracking safety issues like bleeding, clotting, and organ function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Extracorporeal ventricular assist system (EVAS) - an external pump that temporarily takes over heart function to maintain blood flow
What this could lead to: If successful, this device could offer a life-saving bridge for people in cardiogenic shock, helping them survive until their heart recovers or they receive a transplant or long-term assist device.
What could go wrong: This is an early pilot study with only 40 patients, so results may not apply broadly. The device carries risks like bleeding, clotting, infection, and organ dysfunction, and it may not improve survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiogenic shock Shock, Cardiogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOGENIC SHOCK

Contacts and locations

Locations

Fuwai Hospital, Chinese Academy of Medical Sciences
RECRUITING

Beijing, Beijing Municipality, 100000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.